Clinical Trial Update: Induction FLOT With CROSS CRT for Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating induction FLOT chemotherapy followed by CROSS chemoradiation for esophageal or gastroesophageal junction adenocarcinoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Adenocarcinoma Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 2 | Status: ACTIVE_NOT_RECRUITING